Weitere Kapitel dieses Buchs durch Wischen aufrufen
In terms of the world’s meta-problems one of the largest demanding immediate attention is the continuing rising costs of healthcare provision. For example, it is estimated that in 2010 Americans spent over $2.6 trillion on healthcare services, representing 17.6 % of the country’s entire GDP (Whittington et al. 2015). This is nearly three times the country’s annual defence spending and twice the level of spending on education (Hartman et al. 2010). The factors influencing this cost spiral include (1) ongoing advances in medical technology, (2) rising levels of obesity and (3) population ageing. This third factor is especially critical because older people are usually affected by expensive illnesses such as cancer, heart diseases and mental problems like dementia. The cost impact of population ageing is reflected by the fact that although in the USA individuals over the age of 65 years represent only 13 % of the population, they account for nearly one-third of healthcare expenses.
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:
Anon. (2005, August). The shrinking lab. IEE Review, 34–38.
Berwick, D. M. (2002). A user’s manual for the IOM’s ‘Quality Chasm’ Report’. Health Affairs, 21(3), 80–90. CrossRef
Boos, D., Guenter, H., Grote, G., & Kinder, K. (2013). Controllable accountabilities: The internet of things and its challenges for organisations. Behaviour & Information Technology, 32(5), 449–467. CrossRef
Borman, S. (1998). Pharma acquisitions (pp. 47–67). London: Chemical and Engineering News.
Chaston, I. (2016). Entrepreneurial Marketing (2 ed.). London: Palgrave Macmillan.
Cockburn, I. M., Henderson, R., & Stern, S. (2000). Untangling the origins of competitive advantage. Strategic Management Journal, 21(10/11), 1123–1145. CrossRef
Coile, R. C. (2000). E-health: Reinventing healthcare in the Information Age. Journal of Healthcare Management, 45(3), 206–2011.
Collins, M. A., & Amabile, T. M. (1999). Motivation and creativity. In R. J. Sternberg (Ed.), Handbook of creativity (pp. 46–59). Cambridge: Cambridge University Press.
Dahl, D. W., & Moreau, P. (2002). The influence and value of analogical thinking during new product ideation. Journal of Marketing Research, 39(2), 47–60. CrossRef
Dunlop, K. J., & Barnetson, R. S. (1995). A comparative study of isolutrol versus benzoyl peroxide in the treatment of acne. Australasian Journal of Dermatology, 36(1), 13–15. CrossRef
Feder, J., Komisar, H., & Niefeld, A. (2000). Long term care in the United States: An overview. Health Affairs, 19(3), 40–56. CrossRef
Fleming, L., & Sorenson, O. (2004). Science as a map in technology search. Strategic Management Journal, 25(8/9), 909–928. CrossRef
Fletcher, L. (2001). Curagen sets precedent in post genomics era. Nature Biotechnologica, 19, 186–187. CrossRef
Fottler, M. D., & Ford, R. (2002). Creating customer focus. In J. Fried & J. A. Johnson (Eds.), Human resources in healthcare: Managing for success (pp. 56–74). Washington, DC: AUPHA Press.
Fuchs, G., & Krauss, G. (2003). Biotechnology in comparative perspective. In G. Fuchs (Ed.), Biotechnology in comparative perspective (pp. 1–13). New York: Routledge. CrossRef
Fuji, K., Galt, K., & Serocca, A. (2008). Personal health record use by patients. Perspectives in Health Information Management, 5(1), 1–16.
Gans, J., & Stern, S. (2004). Managing ideas: Commercialization strategies for biotechnology. Chicago: Northwestern Academic Press.
Gassman, O., Reepmeyer, G., & Zedwitz, M. V. (2004). Leading pharmaceutical innovation: Trends and drivers for growth in the pharmaceutical industry. New York: Springer. CrossRef
Gilman, M., & Stensland, J. (2013). Telehealth and medicare: Payment policy, current use, and prospects for growth. Medicare & Medicaid Research Review, 3(4), 1–14. CrossRef
Gruner, K. E., & Homburg, C. (2000). Does customer interaction enhance new product success? Journal of Business Research, 49(1), 1–14. CrossRef
Hartman, M., Martin, A., McDonnell, P., & Catlin, A. (2010). Slower drug spending contributes to lowest rate of overall growth since 1998. Health Affairs, 28, 246–261. CrossRef
Hobbs, J. E. (2002). Evolving supply chains in the nutraceuticals and functional foods industry. Canadian Journal of Agricultural Economics, 50, 559–568. CrossRef
Kastor, J. A. (2001). Mergers of teaching hospitals in Boston. New York and Northern California: University of Michigan Press and Ann Arbour.
Kristensson, P., Gustafsson, A., & Archer, T. (2004). Harnessing the creative potential among users. Journal of Product Innovation Management, 21(1), 4–14. CrossRef
Lanser, G. (2000, September/October). Lessons from the business side of healthcare. Healthcare Executive, 14–19.
Lanterman, M. (2015). Not what the doctor ordered: Security concerns in light of evolving health technologies. Journal of Health Care Compliance, 17(4), 5–11.
Lett, C., Herstatt, C., & Gemuenden, H. G. (2006). Users’ contributions to radical innovation: Evidence from four cases in the field of medical equipment technology. R&D Management, 36(3), 251–268. CrossRef
Liebeskind, J., Lumerman, A., Zucker, O., Lynne, G., & Brewer, M. B. (1995). Social networks, learning, and flexibility: Sourcing scientific knowledge in new biotechnology firms, NBER Paper 5320. Cambridge, MA: National Bureau of Economic Research. CrossRef
Luiten, E. E. M., Akkerman, I., Koulman, A., Kamer-mans, P., Reith, H., Barbosa, M. J., et al. (2003). Realizing the promises of marine biotechnology. Biomolecular Engineering, 20, 429–439. CrossRef
Macrides, T. A., Naylor, L. M., Kalafatis, N., Shihata, A., & Wright, P. F. A. (1996). Hepatoprotective effects of the shark bile salt 5/b-scymnol on aceta-minophen-induced liver damage in mice. Fundamental and Applied Toxicology, 33, 31–37. CrossRef
Mair, J., Marti, I., & Canly, K. (2007). Institutional voids as spaces of opportunity. European Business Forum, 31(1), 35–39.
Manojlovich, M., & Laschinger, H. (2002). The relationship of empowerment and selected personality characteristics to nursing job satisfaction. Journal of Nursing Administration, 32, 586–595. CrossRef
McCleary, K., Rivers, P., & Schneller, G. (2006). A diagnostic approach to understanding entrepreneurship in healthcare. JHHSA, 550–562.
McLean, C. (2002). The good oil. Seafood New Zealand, 10(8), 18–19.
Meliones, J. (2000, November–December). Saving money, saving lives. Harvard Business Review, 57–65.
Mendola, D. (2003). Aquaculture of three phyla of marine invertebrates to yield bioactive metabolites: Process developments and economics. Biomolecular Engineering, 20, 441–458. CrossRef
Moore, D., & Coddington, D. (1999). The transformation ahead. Health Forum Journal, 42, 18–27.
Müller, C., Fujiwara, T., & Herstatt, C. (2004). Bio-entrepreneurship in Germany and Japan. Journal of Small Business Management, 42(1), 93–101. CrossRef
National Coordinator for Health Information Technology. (2006). Retrieved May 2016, from www.hhs.gov/healthit/ahic/materials/01_07/ce/PrivacyReview.pdf
O’Connor, G. C., & Veryzer, R. (2001). The nature of market visioning for technology-based radical innovation. The Journal of Product Innovation Management, 18, 231–246. CrossRef
Phillip, F. S., & Garman, A. N. (2006). Barriers to entrepreneurship in healthcare organisations, Journal of Health & Human Services Administration, 28(4), 471–486.
Pisano, G. P. (2006). Science business. Boston, MA: Harvard Business School Press.
Powell, W. W., Koput, K., & Smith-Doerr, L. (1996). Interorganizational collaboration and the locus of innovation: Networks of learning in biotechnology. Administrative Science Quarterly, 41(1), 116–145. CrossRef
Rangan, V. K. (2009). The Aravind Eye Hospital, Madurai, India: In service for sight. Harvard Business School Case Study No. 9-593-098. Boston, MA: Harvard University Press.
Robinson, J. C. (2001). Academic medical centers and the economics of innovation in health care. In H. J. Aaron (Ed.), The future of academic medical centers (pp. 49–60). Washington, DC: Brookings Institution Press.
Reinke, T. (2015). Leading health systems switch focus from genetics to genomes. Physician Leadership Journal Advances, 2(2), 29–34.
Persidis, A. (1995). Enabling technologies and the business of science. Bio-Technology, 13, 1172–1176. CrossRef
Rothman, H., & Kraft, H. (2006). Downstream and into deep biology: Evolving business models in ‘top tier’ genomics companies. Journal of Commercial Biotechnology, 12(2), 86–98. CrossRef
Sankaran, J. K., & Mouly, S. (2007). Managing innovation in an emerging sector: The case of marine-based nutraceuticals. R&D Management, 37(4), 329–338. CrossRef
Seninger, S. F. (2001). Information linkages in regional market networks with applications to healthcare markets. Papers in Regional Science, 80(1), 87–103. CrossRef
Shaista, E., Khilji, I., Mroczkowski, T., & Bernstein, B. (2006). From invention to innovation: Toward developing an integrated innovation model for biotech firms. Journal of Product Innovation, 23, 528–540. CrossRef
Sipkema, D., & Wijffels, R. H. (2003). Realizing the promises of marine biotechnology. Biomolecular Engineering, 20, 429–439. CrossRef
Steele, R., Min, K., & Lo, A. (2012). Personal health records architecture. Journal of American Society for Information Sciences, 63(6), 1079–1091.
Srivastava, S. C., & Shainesh, G. (2015). Bridging the service delivery divide through digitally enabled service innovation, evidence from Indian healthcare service providers. MIS Quarterly, 39(1), 245–267.
Vargo, S. L., & Lusch, R. F. (2004). Evolving to a new dominant logic for marketing. Journal of Marketing, 68, 1–17. CrossRef
Vargo, S. L., & Lusch, R. F. (2008). Service-dominant logic: Continuing the evolution. Journal of the Academy of Marketing Science, 36(1), 1–10. CrossRef
Vargo, S. L., Maglio, P. P., & Akaka, M. A. (2008). On value and value co-creation: A service systems and service logic perspective. European Management Journal, 26, 145–152. CrossRef
Verleye, K., & Gemmel, P. (2011). Innovation in the elderly care sector—At the edge of chaos. Journal of Management & Marketing in Healthcare, 4(2), 121–134. CrossRef
von Hippel, E. (1998). Economics of product development by users: The impact of “sticky” local information. Management Science, 44(5), 629–644. CrossRef
Whittington, J. W., Nolan, K., Lewis, N., & Torres, T. (2015). Pursuing the triple aim: The first 7 years. Milbank Quarterly, 93(2), 263–300. CrossRef
Williams, J. (2012). The value of mobile apps in health care (pp. 96–103). New York: Healthcare Financial Management.
Neuer Inhalt/© Stellmach, Neuer Inhalt/© Maturus, Pluta Logo/© Pluta, digitale Transformation/© Maksym Yemelyanov | Fotolia